fluorodeoxyglucose f18 has been researched along with Mucocutaneous Lymph Node Syndrome in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abo, Y; Akikusa, J; Burgner, D; Danchin, MH; Francis, P | 1 |
| Abe, T; Bekki, M; Fujimoto, K; Fukumoto, Y; Honda, A; Iemura, M; Kagiyama, Y; Kishimoto, S; Nakamura, T; Suda, K; Tahara, N | 1 |
| Abe, T; Bekki, M; Fujimoto, K; Fukumoto, Y; Honda, A; Igata, S; Kurata, S; Nakamura, T; Suda, K; Sugiyama, Y; Sun, J; Tahara, A; Tahara, N; Tanaka, H | 1 |
| Abe, T; Fukumoto, Y; Honda, A; Kaida, H; Kishimoto, S; Kudo, Y; Suda, K; Tahara, N; Ueno, T; Yoshimoto, H | 1 |
| Konishi, J; Matsumura, M; Mikawa, H; Nishioka, K; Tamaki, N; Temma, S; Ueda, T; Yamashita, K; Yonekura, Y; Yoshibayashi, M | 1 |
5 other study(ies) available for fluorodeoxyglucose f18 and Mucocutaneous Lymph Node Syndrome
| Article | Year |
|---|---|
FDG-PET imaging in a child with Kawasaki disease: systemic and coronary artery inflammation without dilatation.
Topics: Child; Coronary Artery Disease; Coronary Vessels; Dilatation; Dilatation, Pathologic; Fluorodeoxyglucose F18; Humans; Inflammation; Mucocutaneous Lymph Node Syndrome; Positron-Emission Tomography | 2022 |
Ongoing vascular inflammation evaluated by
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Mucocutaneous Lymph Node Syndrome; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Anti-inflammatory effect of statin in coronary aneurysms late after Kawasaki disease.
Topics: Adult; Anti-Inflammatory Agents; Computed Tomography Angiography; Coronary Aneurysm; Coronary Angiography; Coronary Artery Bypass; Coronary Vessels; Disease Progression; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Mucocutaneous Lymph Node Syndrome; Positron-Emission Tomography | 2019 |
Statin reduces persistent coronary arterial inflammation evaluated by serial ¹⁸fluorodeoxyglucose positron emission tomography imaging long after Kawasaki disease.
Topics: Adult; Coronary Artery Disease; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Mucocutaneous Lymph Node Syndrome; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors | 2015 |
Regional myocardial perfusion and metabolism assessed by positron emission tomography in children with Kawasaki disease and significance of abnormal Q waves and their disappearance.
Topics: Adolescent; Ammonia; Child; Child, Preschool; Coronary Angiography; Coronary Circulation; Coronary Disease; Deoxyglucose; Electrocardiography; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mucocutaneous Lymph Node Syndrome; Myocardial Infarction; Myocardium; Nitrogen Radioisotopes; Radionuclide Ventriculography; Tomography, Emission-Computed; Ventricular Function, Left | 1991 |